US2005009762A1PendingUtilityA1

Application of water and organic solvent soluble ivermectin for topical and oral use

Priority: Jun 6, 2003Filed: Jun 6, 2003Published: Jan 13, 2005
Est. expiryJun 6, 2023(expired)· nominal 20-yr term from priority
Inventors:Michael Strobel
A61K 9/0095A61K 31/045A01N 43/90A61K 31/35A61K 31/7048A61K 9/0017
58
PatentIndex Score
0
Cited by
0
References
0
Claims

Abstract

A stable, palatable solution of Ivermectin in water is provided for the mass medication of animals. The present formulation does not require the use of benzyl alcohol and is stable indefinitely in the concentrated form and for up to 30 days when mixed with water.

Claims

exact text as granted — not AI-modified
1 . A pharmaceutical solution comprising Ivermectin, ethyl alcohol, and polysorbate 80, without benzyl alcohol, N-methylpyrrolidone or 2-pyrrolodone for the treatment of a broad spectrum of infestations caused by a parasite.  
     
     
         2 . The pharmaceutical solution of  claim 1 , wherein the solution is applied topically.  
     
     
         3 . The pharmaceutical solution of  claim 1 , wherein the solution further comprises water or an organic solvent.  
     
     
         4 . The pharmaceutical solution of  claim 1 , wherein the solution further comprises a flavoring agent.  
     
     
         5 . The pharmaceutical solution of  claim 1 , wherein said solution is a water based solution.  
     
     
         6 . The pharmaceutical solution comprising Ivermectin, isopropyl alcohol and polysorbate 80, without benzyl alcohol, N-methylpyrrolidone or 2-pyrrolodone for the treatment of a broad spectrum of infestations caused by a parasite.  
     
     
         7 . The pharmaceutical solution of  claim 6 , wherein the solution is applied topically.  
     
     
         8 . The pharmaceutical solution of  claim 6 , wherein the solution further comprises water or an organic solvent.  
     
     
         9 . The pharmaceutical solution of  claim 6 , wherein the solution further comprises a flavoring agent.  
     
     
         10 . The pharmaceutical solution of  claim 6 , wherein said solution is a water based solution.  
     
     
         11 . A pharmaceutical solution comprising comprising Ivermectin, without benzyl alcohol, N-methylpyrrolidone or 2-pyrrolodone, in an amount of 0.1-10% by weight of the solution, mixed with a solution of 50% propylene glycol and 50% polysorbate 80 by volume, for the treatment of infestations caused by a parasite.  
     
     
         12 . The pharmaceutical solution of  claim 11 , wherein the solution is applied topically.  
     
     
         13 . The pharmaceutical solution of  claim 11 , wherein the solution further comprises water or an organic solvent.  
     
     
         14 . The pharmaceutical solution of  claim 11 , wherein the solution further comprises a flavoring agent.  
     
     
         15 . The pharmaceutical solution of  claim 11 , wherein said solution is a water based solution.  
     
     
         16 . A method for preparing a stable, palatable form of Ivermectin comprising the following steps: 
 a. adding Ivermectin to the propylene glycol to form a mixture;    b. adding Tween 80 as a coupling agent to said mixture; and    c. stirring for 12 to 24 hours.    
     
     
         17 . A method as in  claim 16  with the additional steps of: 
 d. adding a flavoring agent; and    e. mixing for 1 hour.    
     
     
         18 . The flavoring agent of  claim 16 , wherein said flavoring agent is selected from the group consisting of cyclohexyl-sulfamic acid, saccharin (o-benzosulfimide), Aspartame (i.e., L-Aspartyl-L-phenylalanine methyl ester), and sugar.

Join the waitlist — get patent alerts

Track US2005009762A1 — get alerts on status changes and closely related new filings.

We store only your email — no account needed. See our privacy policy.